Clinical Trial Update: Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated delaying mycophenolate mofetil in single-donor islet transplantation for Type 1 diabetes mellitus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University of Minnesota | Conditions: Type 1 Diabetes, Hypoglycemia | Phase 1, Phase 2 | Status: COMPLETED